BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says

Reuters

Nov 17, 2025

BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, <a href="https://laohu8.com/S/EVR">Evercore</a> says

** GE Healthcare GEHC.O says Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden adoption of co's Flyrcado injection

** Flyrcado is a type of medical dye used during a heart scan to check how well the blood is flowing

** The deal with CVAUSA could lead to annualized revenue opportunity over time worth more than $300 mln- Evercore ISI

** CVAUSA says it plans to use Flyrcado across about 25 sites

** "While the pace of adoption across the 25 sites will determine time for GEHC to hit the peak >$300M revs, we think the economic incentives & image quality make a strong case for quicker adoption cycle"- Evercore

** Up to last close, stock down 6.4% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2584768629"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2584768629\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2584768629?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-17 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584768629","market":"us","top_or_hot":-1,"title":"BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, <a href=\"https://laohu8.com/S/EVR\">Evercore</a> says   </title></head><body><p>** GE Healthcare <span>GEHC.O</span> says Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden adoption of co's Flyrcado injection</p><p>** Flyrcado is a type of medical dye used during a heart scan to check how well the blood is flowing </p><p>** The deal with CVAUSA could lead to annualized revenue opportunity over time worth more than $300 mln- Evercore ISI</p><p>** CVAUSA says it plans to use Flyrcado across about 25 sites  </p><p>** \"While the pace of adoption across the 25 sites will determine time for GEHC to hit the peak &gt;$300M revs, we think the economic incentives &amp; image quality make a strong case for quicker adoption cycle\"- Evercore </p><p>** Up to last close, stock down 6.4% YTD </p><p> (Reporting by Sneha S K)</p><p> ((Sneha.SK@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, <a href=\"https://laohu8.com/S/EVR\">Evercore</a> says   </title></head><body><p>** GE Healthcare <span>GEHC.O</span> says Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden adoption of co's Flyrcado injection</p><p>** Flyrcado is a type of medical dye used during a heart scan to check how well the blood is flowing </p><p>** The deal with CVAUSA could lead to annualized revenue opportunity over time worth more than $300 mln- Evercore ISI</p><p>** CVAUSA says it plans to use Flyrcado across about 25 sites  </p><p>** \"While the pace of adoption across the 25 sites will determine time for GEHC to hit the peak &gt;$300M revs, we think the economic incentives &amp; image quality make a strong case for quicker adoption cycle\"- Evercore </p><p>** Up to last close, stock down 6.4% YTD </p><p> (Reporting by Sneha S K)</p><p> ((Sneha.SK@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nL4N3WT0XJ:1","article_id":"2584768629","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584768629","pubTimestamp":1763388450,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says** GE Healthcare GEHC.O says Cardiovascular Associates of America , the largest network of private cardiology groups in the U.S., plans to broaden adoption of co's Flyrcado injection** Flyrcado is a type of medical dye used during a heart scan to check how well the blood is flowing ** The deal with CVAUSA could lead to annualized revenue opportunity over time worth more than $300 mln- Evercore ISI** CVAUSA says it plans to use Flyrcado across about 25 sites  ** \"While the pace of adoption across the 25 sites will determine time for GEHC to hit the peak >$300M revs, we think the economic incentives & image quality make a strong case for quicker adoption cycle\"- Evercore ** Up to last close, stock down 6.4% YTD   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC","BK4588":"碎股","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4082":"医疗保健设备","EVR":"Evercore","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","BK4127":"投资银行业与经纪业"},"translate_title":"Buzz-Evercore表示，GE Healthcare着眼于在美国采用Flyrcado带来3亿美元的机会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":0.9,"EVR":0.9},"content_text":"BUZZ-GE Healthcare eyes $300 million opportunity with Flyrcado adoption in US, Evercore says   ** GE Healthcare GEHC.O says Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden adoption of co's Flyrcado injection** Flyrcado is a type of medical dye used during a heart scan to check how well the blood is flowing ** The deal with CVAUSA could lead to annualized revenue opportunity over time worth more than $300 mln- Evercore ISI** CVAUSA says it plans to use Flyrcado across about 25 sites  ** \"While the pace of adoption across the 25 sites will determine time for GEHC to hit the peak >$300M revs, we think the economic incentives & image quality make a strong case for quicker adoption cycle\"- Evercore ** Up to last close, stock down 6.4% YTD  (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}